Skip to main navigation
Skip to main content
  • Email Alerts
  • News
  • Lilly.com
  • Stock Info
    Expand mega menu
    Expand submenu
    Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Dividends & Stock Splits
  • Webcasts & Presentations
  • Financials
    Expand mega menu
    Expand submenu
    Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
    • Interactive Financials
    • Debt Securities
  • Individual Investors
  • Resources
    Expand mega menu
    Expand submenu
    Resources
    • Clinical Development Pipeline
    • Current Medicines
    • Executive Committee
    • Key Facts
    • 2020 Integrated Summary Report
    • 2020 ESG Report
  • Email Alerts
  • News
  • Lilly.com

Investors

Investors

Latest News

October 19, 2021

Tirzepatide results published in The Lancet show superior A1C and body weight reductions compared to insulin glargine in adults with type 2 diabetes with increased cardiovascular risk

October 18, 2021

Lilly Declares Fourth-Quarter 2021 Dividend

October 14, 2021

Lilly Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology

View All

Upcoming Events

October 26, 2021 at 9:00 AM EDT

Q3 2021 Earnings Call

February 3, 2022 at 9:00 AM EST

Q4 2021 Earnings Call

View All
two people talking in library with laptop

Clinical Development Pipeline

Learn More
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

Quarterly Results

View Results
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

2020 Integrated Summary Report

View This Report
people talking at the table of a team building lunch with red balloons

Key Ratios

Key Financial Ratios
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

ESG

Learn More
wide shot of two scientists in lab

Investor Email Alerts

Sign up to receive email alerts for various types of investor content.

Diversity
Contact
Suppliers
Login
Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call (800) 545-5979

Copyright © 2021 Eli Lilly and Company. All rights reserved.
Twitter Facebook Instagram LinkedIn YouTube
Terms of Use Privacy Statement Accessibility Statement Sitemap